How effectively does Melanotan 2 suppress appetite compared to stimulant-based diet aids?

Melanotan 2 suppresses appetite centrally via MC4R agonism in the hypothalamus, reducing hunger drive at its neurological source rather than masking it through adrenergic stimulation. This makes it distinctly effective for athletes who have developed tolerance to caffeine-based suppressants or who need to avoid stimulants during a cut. Most users report a meaningful reduction in meal-size cravings within the first few days of use.

Does Melanotan 2 help control food cravings specifically, or only overall caloric hunger?

MC4R activation reduces both generalised hunger and the reward-driven urge to overeat, addressing two separate hunger pathways simultaneously. Users frequently note that the appeal of high-calorie snack foods diminishes alongside overall appetite, making adherence to a structured meal plan considerably easier than with caloric restriction alone.

When does the appetite-suppressing effect of Melanotan 2 typically begin?

Central appetite suppression generally becomes noticeable within 24–48 hours of the first subcutaneous dose at 0.25–0.5 mg, based on standard peptide research dosing protocols. The effect strengthens over the first week as peptide exposure accumulates, then stabilises. Dieting ease is typically most pronounced during the second and third weeks of consistent use.

Why is the 10 mg/vial format of Melanton II useful for appetite-suppression dosing specifically?

The 10 mg/vial format provides straightforward dose titration: reconstituted in 1 mL of bacteriostatic water, each 0.1 mL drawn in an insulin syringe delivers 1 mg — giving precise control when starting at conservative 0.25–0.5 mg doses. Higher-concentration vials increase the risk of dosing errors at these low starting amounts, making the 10 mg format the most practical entry point for appetite-focused protocols.

How should Melanton II 10 mg/vial be stored after reconstitution to maintain potency?

Once reconstituted, the vial should be stored in a refrigerator at 2–8 °C and kept away from direct light. The lyophilised powder is stable at room temperature until opened; after reconstitution, refrigerated storage preserves peptide integrity for the duration of use. Freezing the reconstituted solution is not recommended as it risks degrading the peptide structure. (2) angle_used

Top Seller

Master Pharma

Melanton II 10mg/vial 1 Vial by Master Pharma

Name: Melanton II
Brand: Master Pharma
SKU: PEPT-MEL2-MAS-004
Price: 35.00 EUR
Availability: InStock

Melanton II is a lyophilised Melanotan 2 peptide, supplied as 10 mg per vial, whose most operationally valuable effect for cutting athletes is centrally mediated appetite suppression driven by melanocortin-4 receptor (MC4R) signalling in the hypothalamus. Unlike stimulant-based appetite suppressants, it does not rely on adrenergic pathways, making it a structurally distinct tool for calorie-deficit management. Each vial's purity and sterility are confirmed by lot-specific HPLC potency analysis and LAL endotoxin quantification — both results locked to the batch number on the label.

€35.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Centrally reduces hunger intensity via hypothalamic MC4R engagement — no adrenergic stimulation required
Supports sustained caloric deficits by lowering both generalised appetite and reward-driven food cravings
10 mg/vial format enables precise subcutaneous dose titration from 0.25 mg with a standard insulin syringe
Lyophilised peptide format ensures stability during storage prior to reconstitution
Lot-specific HPLC and LAL testing provides a verified potency and sterility baseline per batch
Non-stimulant mechanism preserves adrenal headroom for athletes already using pre-workout compounds
Single-vial supply allows a structured loading and maintenance appetite-suppression protocol without surplus stock

Phase	Dosage	Note
Titration (Days 1–7)	0.25 mg subcutaneous, once daily	Assess appetite response and tolerability; nausea is most likely at initiation — dosing before bed reduces discomfort
Appetite Suppression Maintenance (Weeks 2–4)	0.5 mg subcutaneous, once daily	Hunger reduction is typically most consistent at this dose; adjust down if satiety becomes excessive
Extended Cut Support (Weeks 5–8)	0.25–0.5 mg subcutaneous, every other day	Reduced frequency maintains appetite control while limiting cumulative peptide exposure over a prolonged deficit phase

Key takeaways

Use Melanton II to reduce hunger drive centrally during a caloric deficit.
Expect appetite suppression onset within 24–48 hours of first dosing.
Choose the 10 mg vial for precise low-dose titration with an insulin syringe.
Verify potency via the lot-specific HPLC Certificate of Analysis before use.
Combine with a structured meal plan to maximise adherence and deficit consistency.

Melanotan 2 as a Centrally Acting Satiety Agent

Melanton II (Melanotan 2, 10 mg/vial) is a synthetic analogue of α-MSH whose primary practical value during a caloric deficit is the reduction of hunger drive through hypothalamic MC4R engagement — a mechanism that operates independently of stimulant or adrenergic pathways. Compared to common cutting agents such as caffeine-based thermogenics, Melanotan 2 suppresses appetite at a central neurological level rather than peripherally masking hunger through sympathetic nervous system activation. This distinction matters for athletes who experience stimulant tolerance or adrenal fatigue during prolonged cuts.

How Central MC4R Activation Reduces Caloric Intake

MC4R agonism by Melanotan 2 reduces food intake by signalling energy sufficiency to the hypothalamic arcuate nucleus — a region directly governing hunger and satiety. Clinical peptide pharmacology literature documents appetite reduction appearing within 24–48 hours of initial subcutaneous administration at doses in the 0.25–0.5 mg range (per standard peptide research protocols). Master Pharma's Melanton II delivers the active peptide in a 10 mg lyophilised format; HPLC confirmation of active content is conducted lot-specifically, providing a verifiable potency baseline before first use.

Practical Benefit for Cutting Phases

Dieting adherence, not macronutrient calculation, is the most common failure point in a cut. Melanton II addresses this by reducing the subjective intensity of hunger, making sustained calorie restriction easier to maintain without constant willpower expenditure. Users typically report that meal portions feel satisfying at lower caloric thresholds, which supports a consistent deficit without aggressive refeeds.

Quality Assurance Behind Every Vial

Master Pharma subjects each lyophilised peptide batch to two independent release criteria: HPLC active-content verification against a traceable reference standard, and LAL endotoxin screening to confirm vial sterility post-lyophilisation. Both results are documented on the lot-specific Certificate of Analysis that accompanies dispatch. The 10 mg/vial format provides a precise, measurable starting point for titrating appetite-suppression protocols without the dose ambiguity of higher-concentration vials.

Usage

Reconstitute the 10 mg lyophilised vial by adding 1 mL of bacteriostatic water slowly down the inner vial wall; swirl the vial gently — do not agitate — until the powder is fully dissolved, yielding a 10 mg/mL solution.
Draw the target dose (e.g. 0.025 mL for 0.25 mg) into a 29–31 gauge insulin syringe, confirming the volume against the syringe's graduated markings before injection.
Select a subcutaneous injection site — lower abdomen or outer thigh — and clean the skin with an alcohol swab; allow it to dry completely before proceeding.
Pinch a small fold of skin and insert the needle at approximately a 45-degree angle into the subcutaneous tissue; depress the plunger steadily and withdraw the needle.
Time your dose to align with your appetite-suppression goal: dosing 30–60 minutes before your largest scheduled meal maximises the hunger-blunting effect at the highest-risk caloric moment of the day.
Refrigerate the reconstituted vial at 2–8 °C between uses and record the reconstitution date on the vial label; discard unused solution after 28 days regardless of remaining volume.

Warnings

Contraindications: Not indicated for individuals with a personal or family history of melanoma or dysplastic nevus syndrome. Avoid use if pregnant, breastfeeding, or under 18 years of age. Those with autoimmune conditions affecting pigmentation should seek medical guidance before use.

Side Effects: Nausea is the most frequently reported side effect, particularly during dose titration; it typically resolves within 3–5 days as tolerance develops. Facial flushing and spontaneous erections may occur and are dose-dependent. Darkening of existing moles or emergence of new nevi warrants immediate discontinuation and dermatological review.

Monitoring: Conduct a baseline skin assessment before starting and monitor any pigmented lesions throughout the protocol. Track appetite changes weekly to avoid excessive caloric restriction beyond the intended deficit. Bloodwork is not routinely required for short cycles but is advisable for extended use.

PCT: Melanotan 2 does not interact with the hypothalamic-pituitary-gonadal axis and requires no post-cycle hormonal recovery protocol. If used alongside anabolic compounds, standard PCT for those compounds applies independently of MT-2 discontinuation.

Frequently asked questions

How effectively does Melanotan 2 suppress appetite compared to stimulant-based diet aids?: Melanotan 2 suppresses appetite centrally via MC4R agonism in the hypothalamus, reducing hunger drive at its neurological source rather than masking it through adrenergic stimulation. This makes it distinctly effective for athletes who have developed tolerance to caffeine-based suppressants or who need to avoid stimulants during a cut. Most users report a meaningful reduction in meal-size cravings within the first few days of use.
Does Melanotan 2 help control food cravings specifically, or only overall caloric hunger?: MC4R activation reduces both generalised hunger and the reward-driven urge to overeat, addressing two separate hunger pathways simultaneously. Users frequently note that the appeal of high-calorie snack foods diminishes alongside overall appetite, making adherence to a structured meal plan considerably easier than with caloric restriction alone.
When does the appetite-suppressing effect of Melanotan 2 typically begin?: Central appetite suppression generally becomes noticeable within 24–48 hours of the first subcutaneous dose at 0.25–0.5 mg, based on standard peptide research dosing protocols. The effect strengthens over the first week as peptide exposure accumulates, then stabilises. Dieting ease is typically most pronounced during the second and third weeks of consistent use.
Why is the 10 mg/vial format of Melanton II useful for appetite-suppression dosing specifically?: The 10 mg/vial format provides straightforward dose titration: reconstituted in 1 mL of bacteriostatic water, each 0.1 mL drawn in an insulin syringe delivers 1 mg — giving precise control when starting at conservative 0.25–0.5 mg doses. Higher-concentration vials increase the risk of dosing errors at these low starting amounts, making the 10 mg format the most practical entry point for appetite-focused protocols.
How should Melanton II 10 mg/vial be stored after reconstitution to maintain potency?: Once reconstituted, the vial should be stored in a refrigerator at 2–8 °C and kept away from direct light. The lyophilised powder is stable at room temperature until opened; after reconstitution, refrigerated storage preserves peptide integrity for the duration of use. Freezing the reconstituted solution is not recommended as it risks degrading the peptide structure. (2) angle_used

Manufacturer

Master Pharma's peptide injectable line — of which Melanton II is a core SKU — is released under a two-gate analytical framework applied identically across every lyophilised vial format the brand produces: HPLC active-content verification against a traceable reference standard, and LAL endotoxin quantification against established safety thresholds. Neither test is conducted on a representative sample basis; both are executed lot-specifically, meaning the Certificate of Analysis dispatched with your Melanton II vial reflects the production batch number on that packaging, not a pooled or averaged figure. Manufacturing site compliance is maintained under EU GMP conditions, with environmental controls and equipment qualification records auditable at the batch level — an infrastructure originally built for the brand's androgenic injectable range and extended without modification to its peptide catalogue.

Product details

Brand	Master Pharma
Active ingredient	melanotan 2
Also known as	Melanotan II, MT-2, Melanotan 2, Melanton II, Master Pharma Melanotan II
Strength	10 mg
Form	Vial
Pack size	1 piece
Item number	PEPT-MEL2-MAS-004

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Lab Tested

MT-2 10mg/vial 1 Vial by Bio-Peptide

MT-2 (Melanotan 2) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) engineered to activate MC1R for eumelanin-driven skin darkening, MC3R/MC4R for appetite reduction, and central MC4R pathways for libido enhancement — all within a single 10 mg lyophilised vial format. Bio-Peptide formulates MT-2 as a lyophilised powder at 10 mg per vial, a quantity that accommodates both conservative sub-milligram loading schedules and reduced-frequency maintenance phases without reformulation. Each batch clears two independent laboratory gates before release: HPLC analysis locks in sequence identity and purity, while LAL endotoxin screening certifies microbiological safety to injection-grade standards.

€36.00

HPLC Verified

Melanotan 2 10mg/vial 1 Vial by Knoll Pharmaceuticals

Knoll Pharmaceuticals Melanotan 2 10 mg/vial is a lyophilised synthetic melanocortin analogue in a single-use vial, formulated for researchers and bodybuilders who require a correctly reconstituted, refrigerated and subcutaneously administered peptide with a documented quality baseline. Each vial delivers 10 mg of Melanotan II as a freeze-dried powder, ready to be drawn up with bacteriostatic water and administered via insulin syringe for precise subcutaneous dosing across multiple sessions. Release standards are enforced at two sequential analytical checkpoints: HPLC confirms sequence identity and quantitative purity of the bulk API, while LAL endotoxin screening certifies the finished vial is free of pyrogenic contamination before dispatch.

€30.00

Batch Tested

MELANOTAN-2 20mg/vial 1 Vial by Bluepeps

Bluepeps Melanotan 2 is a synthetic melanocortin-receptor agonist supplied as 20 mg lyophilised peptide per vial — the highest concentration available in this range — uniquely suited for use during a bridge or PCT phase because it does not engage the hypothalamic-pituitary-gonadal axis and therefore carries no suppressive risk to endogenous hormone recovery. Athletes bridging between cycles can leverage its melanocortin-mediated effects on tissue and appetite without compromising the hormonal rebound that PCT depends on. Batch-released quality is enforced through a dual-gate protocol: reversed-phase HPLC confirms sequence integrity and active-content accuracy; a Limulus Amebocyte Lysate assay independently verifies that endotoxin load sits within defined safety limits.

€50.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00